Actual Medicinal Product (AMP) Monit SR 40mg tablets (Sanofi-Synthelabo Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Store in airtight containers.
- Provenance
-
This compatibility recommendation is derived from Isotard 40XL tablets (Kyowa Kirin Ltd), Modisal XL 40mg tablets (Ennogen Pharma Ltd) and Zemon 40 XL tablets (Kent Pharma (UK) Ltd).
- Generic
- Isosorbide mononitrate
- Formulation
- Isosorbide mononitrate 40mg modified-release tablets
-
Isosorbide mononitrate
-
Isosorbide mononitrate 40mg modified-release tablets
-
Monit SR 40mg tablets (Sanofi-Synthelabo Ltd)
-
-
Isosorbide mononitrate 40mg tablets